Individuals with the highest levels of trimethylamine-N-oxide, a compound produced in the stomach, were 2.5 times more likely to suffer a heart attack, stroke or heart disease than were those with the lowest TMAO levels, a study showed. The compound can make it more difficult for the liver and intestines to remove cholesterol, lead researcher Dr. Stanley Hazen said. The findings were published in The New England Journal of Medicine.
TMAO compound may play role in cardiovascular disease risk
SmartBrief Job Listings for Health Care
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
Meridian Health Plan